Full Text
PGI24 COST UTILITY ANALYSIS OF CERTOLIZUMAB PEGOL VERSUS NATALIZUMB MAINTENANCE THERAPY FOR CROHNS DISEASE

Abstract

Authors

B Wu

Back to Volume 13, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×